Glioblastoma
📧 Sign up to get email alerts when something new happens for Glioblastoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2012-03-30Clinical Trial Update: Measuring Non-Enhancing Glioblastoma Progression
A completed clinical trial update describing methods for measuring progression in non-enhancing glioblastoma.
-
CLINICAL_TRIALS trial_result · 2012-03-22Clinical Trial Update: Effect of Radiation Therapy Plus Temozolomide Combined With Cilengitide or Cetuximab on the 1-year Overall Survival of Patients With Newly Diagnosed MGMT-promoter Unmethylated Glioblastoma [Phase 2]
This Phase 2 trial evaluating radiation therapy and temozolomide with either cilengitide or cetuximab for newly diagnosed MGMT-promoter unme…
-
CLINICAL_TRIALS trial_result · 2012-03-08Clinical Trial Update: Talampanel in Treating Patients With Recurrent High-Grade Glioma [Phase 2]
Phase 2 clinical trial of talampanel for recurrent high-grade glioma has completed.
-
CLINICAL_TRIALS trial_result · 2012-03-06Clinical Trial Update: Erlotinib in Treating Patients With Progressive Glioblastoma Multiforme [Phase 1]
A Phase 1 trial evaluating erlotinib in patients with progressive glioblastoma multiforme has been terminated.
-
CLINICAL_TRIALS withdrawal · 2012-02-22Clinical Trial Update: Procarbazine and Isotretinoin in Treating Patients With Recurrent Primary Malignant Gliomas [Phase 3]
A Phase 3 trial assessing procarbazine with isotretinoin for recurrent primary malignant gliomas has been withdrawn.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS withdrawal · 2012-02-20Clinical Trial Update: SCH-900105 in Recurrent Glioblastoma [Phase 1]
A Phase 1 trial of SCH-900105 for recurrent glioblastoma has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2012-02-07Clinical Trial Update: The Effect of Monoclonal Vascular Endothelial Growth Factor (VEGF) Antibody (Bevacizumab) on Pituitary Function
A completed clinical trial investigating the effect of bevacizumab (VEGF antibody) on pituitary function in patients with colorectal cancer,…
-
CLINICAL_TRIALS trial_result · 2012-02-06Clinical Trial Update: Lapatinib in Treating Young Patients With Recurrent or Refractory Central Nervous System Tumors [Phase 1, Phase 2]
This clinical trial update summarizes the results of a Phase 1/2 study evaluating lapatinib in pediatric patients with recurrent or refracto…
-
CLINICAL_TRIALS trial_result · 2012-01-16Clinical Trial Update: Dietary Methionine Restriction Plus Temozolomide for Recurrent GBM [Phase 1]
Phase 1 trial of dietary methionine restriction with temozolomide for recurrent glioblastoma was terminated.
-
CLINICAL_TRIALS trial_result · 2012-01-11Clinical Trial Update: 6-TG, Capecitabine and Celecoxib Plus TMZ or CCNU for Anaplastic Glioma Patients [Phase 2]
Phase 2 trial assessing a multi-drug regimen including 6-thioguanine, capecitabine, and celecoxib with temozolomide or lomustine in patients…
-
CLINICAL_TRIALS trial_result · 2012-01-06Clinical Trial Update: Evaluating Tumor Pseudoprogression With FLT-PET and MRI [EARLY_Phase 1]
An EARLY Phase 1 clinical trial evaluating tumor pseudoprogression using FLT-PET and MRI in glioblastoma was terminated.
-
CLINICAL_TRIALS trial_result · 2011-12-30Clinical Trial Update: Phase III Trial of Primary Radio- or Chemotherapy in Malignant Astrocytoma of the Elderly [Phase 3]
A Phase III trial evaluating primary radiotherapy or chemotherapy in elderly patients with malignant astrocytoma (glioblastoma or anaplastic…
-
CLINICAL_TRIALS withdrawal · 2011-12-20Clinical Trial Update: A Study Of Crizotinib Plus VEGF Inhibitor Combinations In Patients With Advanced Solid Tumors. [Phase 1]
A Phase 1 clinical trial evaluating crizotinib in combination with a VEGF inhibitor for advanced solid tumors has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2011-12-08Clinical Trial Update: Aspirin Prophylaxis for Venous Thromboembolism in Glioblastoma [Phase 2]
Phase 2 trial evaluating aspirin prophylaxis to prevent venous thromboembolism in glioblastoma was terminated, with results posted in 2011.
-
CLINICAL_TRIALS trial_result · 2011-10-14Clinical Trial Update: Phase 2 Study MPC-6827 for Recurrent Glioblastoma Multiforme [Phase 2]
Phase 2 study of MPC-6827 for recurrent glioblastoma has completed.
-
CLINICAL_TRIALS trial_result · 2011-09-15Clinical Trial Update: Patupilone (EPO 906) in Patients With Recurrent or Progressive Glioblastoma [Phase 1, Phase 2]
This document reports on a Phase 1/2 trial of patupilone (EPO 906) in patients with recurrent or progressive glioblastoma, now completed.
-
CLINICAL_TRIALS trial_result · 2011-08-05Clinical Trial Update: Safety & Radiation Distribution Study of Cotara® in Patients With Recurrent Glioblastoma Multiforme [Phase 1]
Phase 1 trial evaluating the safety and radiation distribution of Cotara in patients with recurrent glioblastoma multiforme has been complet…
-
CLINICAL_TRIALS trial_result · 2011-07-26Clinical Trial Update: Temozolomide and Procarbazine With Cilengitide for Patients With Glioblastoma Multiforme Without Methylation of the MGMT Promoter Gene [Phase 2]
Phase 2 clinical trial evaluating a combination of temozolomide, procarbazine, and cilengitide in newly diagnosed MGMT unmethylated glioblas…
-
CLINICAL_TRIALS trial_result · 2011-07-11Clinical Trial Update: Gefitinib and Radiation Therapy in Treating Children With Newly Diagnosed Gliomas [Phase 1, Phase 2]
A pediatric Phase 1/2 trial evaluated gefitinib in combination with radiation therapy for newly diagnosed gliomas; the study completed and r…
-
CLINICAL_TRIALS trial_result · 2011-06-06Clinical Trial Update: Imaging Study of the Distribution of IL13-PE38QQR Infused Before and After Surgery in Adult Patients With Recurrent Malignant Glioma [Phase 1]
Phase 1 imaging study evaluating how the IL13-PE38QQR conjugate distributes in adult patients with recurrent malignant glioma before and aft…
-
FDA approval · 2011-06-03FDA Approved: TEMODAR — Supplemental Application (Merck Sharp & Dohme LLC)
FDA approved a supplemental application for Temodar (temozolomide) submitted by Merck Sharp & Dohme LLC.
-
CLINICAL_TRIALS trial_result · 2011-03-28Clinical Trial Update: Carboplatin Plus Irinotecan in Treating Patients With Glioblastoma Multiforme [Phase 2]
A Phase 2 trial evaluating carboplatin plus irinotecan for glioblastoma has completed.
-
CLINICAL_TRIALS trial_result · 2011-03-25Clinical Trial Update: Phase 1 Study of MPC-6827 and Carboplatin in Recurrent/Relapsed Glioblastoma Multiforme [Phase 1, Phase 2]
The document reports an early-phase (Phase 1/2) study evaluating MPC-6827 in combination with carboplatin for recurrent glioblastoma.
-
CLINICAL_TRIALS research · 2011-03-17Clinical Trial Update: Access Protocol for MAB-425 Radiolabeled With I-125 for High Grade Gliomas [NA]
An access protocol update for a trial using MAB-425 radiolabeled with I-125 to treat high-grade gliomas, with the trial status listed as unk…
-
CLINICAL_TRIALS trial_result · 2011-03-04Clinical Trial Update: Metronomic Temozolamide in Patients With Recurrent Glioblastoma [Phase 2, Phase 3]
A clinical trial update on metronomic temozolomide for patients with recurrent glioblastoma, spanning Phase 2 and Phase 3. The trial status …